Stereotaxis, Inc. (STXS) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

High Risk
Significant dilution risk
Last updated: May 13, 2026

Risk Assessment Details

Potential Dilution: 277.42% of current shares
Recent Dilution: 19.27% (2 years)
Historical Dilution Factor: moderate recent dilution
Outstanding Shares
99M
Potential Supply
270M
Additional shares possible
Splits
None
Past 2 years

Summary

STXS currently has 98.9M outstanding shares. with significant dilution risk as 274M authorized shares could dilute existing holders by 277.4%. The company has diluted shareholders by 19.27% over the past 2 years through share issuances.

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
May 13, 2026

10-Q filing | 98.9M shares outstanding

99M 270M
Mar 13, 2026

S-3 filing: This S-3 filing indicates that the company may offer and sell up to $100,000,000 in the aggregate of debt securities, common stock, preferred stock, warrants, rights or units consisting of any two or more of such securities via a shelf registration.

97M 270M
Mar 12, 2026

10-K filing | 91.0M shares outstanding

91M 190M
Nov 12, 2025

10-Q filing | 92.0M shares outstanding

92M 190M
Jul 17, 2025

8-K filing: Stereotaxis, Inc. entered into a placement agency agreement with Lake Street Capital Markets, LLC and a securities purchase agreement with certain investors to sell $12.5 million shares of common stock in a registered direct offering. ($12.5M proceeds)

88M 190M
May 13, 2025

10-Q filing | 87.8M shares outstanding

88M 190M
Mar 14, 2025

10-K filing | 85.2M shares outstanding

85M 190M
Nov 14, 2024

10-Q filing | 85.8M shares outstanding

86M 190M
Sep 06, 2024

S-3/A filing: This S-3/A filing relates to the resale of up to 6,100,000 shares of common stock by the Selling Stockholder, APT Holding Company, Inc., acquired in connection with the acquisition of Access Point Technologies EP, Inc.

85M 190M
Aug 23, 2024

S-3 filing: This S-3 filing relates to the resale of up to 6,100,000 shares of common stock by the selling stockholder, APT Holding Company, Inc., acquired in connection with the acquisition of Access Point Technologies EP, Inc.

85M 190M
Aug 14, 2024

10-Q filing | 84.6M shares outstanding

85M 190M
Aug 02, 2024

8-K filing: Stereotaxis, Inc. completed the acquisition of Access Point Technologies EP, Inc. and issued 1,486,620 shares of its common stock as Upfront Stock Consideration on July 31, 2024.

83M 190M
May 16, 2024

8-K filing: Stereotaxis, Inc. entered into a Share Purchase Agreement with APT Holding Company, Inc. to acquire all equity interests of Access Point Technologies EP, Inc., paying upfront consideration of Stereotaxis common stock subject to closing conditions and a negative net working capital adjustment, as well as additional stock consideration pursuant to earnout provisions.

83M 190M
May 15, 2024

10-Q filing | 83.5M shares outstanding

83M 190M
Mar 08, 2024

10-K filing | 80.7M shares outstanding

81M 190M
Nov 13, 2023

10-Q filing | 82.5M shares outstanding

82M 190M
Aug 11, 2023

10-Q filing | 81.0M shares outstanding

81M 190M
Jun 01, 2023

S-3/A filing: The prospectus included in the S-3 Registration Statement is a combined prospectus which relates to (i) the Registration Statement on Form S-1 (File No. 333-214255) relating to an aggregate of 86,065,014 shares of the registrant's common stock and (ii) the registration of 10,000,000 additional shares of the registrant's common stock for resale by the selling stockholders as set forth in the S-3 Registration Statement.

77M 190M
May 19, 2023

S-3 filing: The company is filing an S-3 shelf registration to offer and sell up to $100,000,000 in the aggregate of debt securities, common stock, preferred stock, warrants, rights or units consisting of any two or more of such securities from time to time.

77M 180M
May 19, 2023

S-3 filing: This prospectus relates to the offer, resale or other disposition of up to an aggregate of 91,221,439 shares of our common stock, comprised of (i) up to 54,921,439 shares issuable upon the conversion of our Series A Convertible Preferred Stock and (ii) 36,300,000 shares of common stock upon exercise of certain related warrants, in each case held by the selling stockholders named in this prospectus or their transferees.

77M 180M
May 12, 2023

10-Q filing | 76.5M shares outstanding

77M 33M
Mar 09, 2023

10-K filing | 76.1M shares outstanding

76M 33M
Nov 14, 2022

10-Q filing | 76.1M shares outstanding

76M 33M
Aug 11, 2022

10-Q filing | 76.0M shares outstanding

76M 33M
May 11, 2022

10-Q filing | 75.9M shares outstanding

76M 33M
Mar 10, 2022

10-K filing | 75.6M shares outstanding

76M 33M
Nov 12, 2021

10-Q filing | 75.7M shares outstanding

76M 33M
Aug 12, 2021

10-Q filing | 75.5M shares outstanding

76M 33M
May 13, 2021

10-Q filing | 75.2M shares outstanding

75M 33M
Mar 12, 2021

10-K filing | 72.7M shares outstanding

73M 33M
Nov 09, 2020

10-Q filing | 74.5M shares outstanding

74M 33M
Aug 06, 2020

10-Q filing | 71.6M shares outstanding

72M 33M
May 26, 2020

8-K filing: Stereotaxis, Inc. entered into a Securities Purchase Agreement with Consonance Capital Opportunity Master Fund, LP and P Consonance Opportunities Ltd. for the registered offering of 3,658,537 shares of the Company's common stock at a price of $4.10 per share, resulting in approximately $15 million of gross proceeds to the Company. ($15.0M proceeds)

59M 33M
May 11, 2020

10-Q filing | 59.1M shares outstanding

59M 33M
Mar 16, 2020

10-K filing | 22.8M shares outstanding

23M 33M
Mar 16, 2020

S-3 filing: The company is filing a shelf registration statement for the potential sale of up to $100,000,000 in debt securities, common stock, preferred stock, warrants, rights, or units.

N/A 33M
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime